-
A Switch From Intravenous to Oral Chemo?
Compared with intravenous paclitaxel, the oral form of the chemotherapy drug was associated with improved tumor shrinkage in metastatic breast cancer patients.
by Ashley P. Taylor
-
Possible New Treatments for Patients With Metastatic HER2-Positive Breast Cancer
Studies presented at the San Antonio Breast Cancer Symposium show additional treatment options.
by Marci A. Landsmann
-
Avoiding Unnecessary Lymph Node Biopsy
A study adds to evidence that many patients with ductal carcinoma in situ do not need to have their lymph nodes removed.
by Cheryl Platzman Weinstock
-
What to Do About Lymphedema?
In a randomized study, weight loss and home-based exercise did not improve lymphedema symptoms in breast cancer survivors.
by Anna Azvolinsky
-
Immunotherapy in the Elderly
Immune checkpoint inhibitors can be effective treatments for elderly people with some types of advanced cancer, but more information is needed on their risks and benefits in this group.
by Emma Yasinski
-
Proton Therapy Is Associated With Reduced Side Effects
When combined with chemotherapy, the newer form of radiation comes with fewer severe side effects than standard radiation therapy, a study suggests.
by Sue Rochman
-
Putting Chemotherapy Side Effects on Ice
A small study shows that keeping ice chips in the mouth during oxaliplatin chemotherapy may prevent cold sensitivity, a common oral side effect.
by Anna Azvolinsky
Previous |
Cancer Talk
Living With Your Loved One’s Prostate Cancer
Christine Ledbetter on the ways her husband’s prostate cancer affected their relationship and finding support as a caregiver.
by Christine Ledbetter
Continuing the ConversationThe AACR hosts a roundtable to ‘get real’ about cancer health disparities.
by Marci A. Landsmann
More Patients Participating in Cancer ResearchA higher proportion of cancer patients are enrolling in research studies than previously thought, but many patients lack the access needed to participate.
by Kyle Bagenstose
Immunotherapy Drug Tarlatamab Approved for Advanced Small Cell Lung CancerThe drug showed promise in treating small cell lung cancer that had progressed during or after chemotherapy.
by Laura Gesualdi-Gilmore